Literature DB >> 26076623

In vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapy.

Yu Cui You1, Ling Ya Dong1, Kai Dong2, Wei Xu2, Yan Yan2, Lu Zhang2, Ke Wang3, Feng Jian Xing4.   

Abstract

The aim of this study was to prepare, characterize novel types of pH-sensitive konjac gum-xanthan gum-glycerol-sodium alginate hydrogel (KGM-XG-GLY-SA hydrogel) allowing for the site-specific delivering of drugs to the colon and evaluate its colon-targeting characteristic. In this study, hydrophilic drug of hydrocortisone sodium succinate (HSS) was chosen as a model drug and successfully loaded in hydrogel without any organic solvent. In vitro investigations were carried out to evaluate its release process. The drug-loaded hydrogel shown good sustained release property that drugs release from test hydrogel was minimal at pH 1.2 (2h, 23.40%), pH 6.8 (4h, 25.88%), and significantly higher (4h, 70.20%) at pH 7.4. It is clear that adding glycerol in hydrogel as hysteresis preparation prevented the rapid dissolution of material in the higher pH of the intestine. Thus ensuring a controlled release of the entrapped drug. We studied the colonic-targeting behavior, in vivo toxicity test, pharmacokinetic study, features to reduce drug toxicity, and therapeutic effect of experimental UC of this preparation. All the results in vitro were shown that the K (KGM-XG-GLY-SA) hydrogels with glycerol had a good colon-targeting characteristic. In addition, results in vivo were indicated that K (KGM-XG-GLY-SA) hydrogel were nontoxic, reduced the spleen and thymus index, and had an obvious effect on the treatment of UC. Therefore, all results suggested that the developed HSS/KGM-XG-GLY-SA hydrogel (HSS-GEL) with glycerol as a colon-targeting vector might have greatly potential application in the UC healing.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Colon-targeting; Glycerol; Hydrogel; Hydrophilic drug; Spleen and thymus index

Mesh:

Substances:

Year:  2015        PMID: 26076623     DOI: 10.1016/j.carbpol.2015.03.075

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  7 in total

1.  Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis.

Authors:  Yan Yan; Jinyao Sun; Xianting Xie; Pengchong Wang; Ying Sun; Yalin Dong; Jianfeng Xing
Journal:  RSC Adv       Date:  2018-01-11       Impact factor: 4.036

Review 2.  Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects.

Authors:  Muhammad Sohail; Muhammad Usman Minhas; Shahzeb Khan; Zahid Hussain; Marcel de Matas; Syed Ahmed Shah; Samiullah Khan; Mubeen Kousar; Kaleem Ullah
Journal:  Drug Deliv Transl Res       Date:  2019-04       Impact factor: 4.617

3.  Development of a chitosan based double layer-coated tablet as a platform for colon-specific drug delivery.

Authors:  Min Soo Kim; Dong Woo Yeom; Sung Rae Kim; Ho Yub Yoon; Chang Hyun Kim; Ho Yong Son; Jin Han Kim; Sangkil Lee; Young Wook Choi
Journal:  Drug Des Devel Ther       Date:  2016-12-21       Impact factor: 4.162

4.  Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis.

Authors:  Yan Yan; Fengling Ren; Pengchong Wang; Ying Sun; Jianfeng Xing
Journal:  Iran J Basic Med Sci       Date:  2019-12       Impact factor: 2.699

Review 5.  Polysaccharide-Based Edible Gels as Functional Ingredients: Characterization, Applicability, and Human Health Benefits.

Authors:  Mihaela Stefana Pascuta; Rodica-Anita Varvara; Bernadette-Emőke Teleky; Katalin Szabo; Diana Plamada; Silvia-Amalia Nemeş; Laura Mitrea; Gheorghe Adrian Martău; Călina Ciont; Lavinia Florina Călinoiu; Gabriel Barta; Dan Cristian Vodnar
Journal:  Gels       Date:  2022-08-21

6.  β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation.

Authors:  Nadia Shamshad Malik; Mahmood Ahmad; Mohammed S Alqahtani; Arshad Mahmood; Kashif Barkat; Muhammad Tariq Khan; Ume Ruqia Tulain; Ayesha Rashid
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

Review 7.  Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease.

Authors:  Muhammad Bilal; Leonardo Vieira Nunes; Marco Thúlio Saviatto Duarte; Luiz Fernando Romanholo Ferreira; Renato Nery Soriano; Hafiz M N Iqbal
Journal:  Mar Drugs       Date:  2021-03-30       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.